NO984974L - Middel som forbedrer pulmonar sirkulasjon - Google Patents
Middel som forbedrer pulmonar sirkulasjonInfo
- Publication number
- NO984974L NO984974L NO984974A NO984974A NO984974L NO 984974 L NO984974 L NO 984974L NO 984974 A NO984974 A NO 984974A NO 984974 A NO984974 A NO 984974A NO 984974 L NO984974 L NO 984974L
- Authority
- NO
- Norway
- Prior art keywords
- pulmonary circulation
- improve pulmonary
- pulmonary
- effect
- circulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Middel til forbedring av pulmonar sirkulasjon som inneholder et prostaglandin l-derivat som aktiv komponent, og har en karutvidende virkning som er selektiv for lungenes blodkar. Middelet har den effekt at det forbedrer pulmonar sirkulasjon ved administrering til en pasient som lider av en økning av karmotstanden i lungene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4436397 | 1997-02-27 | ||
PCT/JP1998/000801 WO1998037895A1 (fr) | 1997-02-27 | 1998-02-26 | Medicaments permettant d'ameliorer la circulation pulmonaire |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984974D0 NO984974D0 (no) | 1998-10-26 |
NO984974L true NO984974L (no) | 1998-12-23 |
Family
ID=12689438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984974A NO984974L (no) | 1997-02-27 | 1998-10-26 | Middel som forbedrer pulmonar sirkulasjon |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0925787A4 (no) |
KR (1) | KR20000065039A (no) |
CN (1) | CN1224354A (no) |
AU (1) | AU6117398A (no) |
CA (1) | CA2253717A1 (no) |
NO (1) | NO984974L (no) |
WO (1) | WO1998037895A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000051980A1 (en) | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | C16 unsaturated fp-selective prostaglandins analogs |
US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
WO2008058766A1 (en) * | 2006-11-16 | 2008-05-22 | Bayer Schering Pharma Aktiengesellschaft | Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
JP2021054725A (ja) * | 2019-09-27 | 2021-04-08 | 学校法人日本医科大学 | イヌ肺高血圧症治療薬 |
WO2021163400A1 (en) | 2020-02-12 | 2021-08-19 | Cytoagents, Inc. | Compositions and methods for treating coronavirus infections |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5931510B2 (ja) * | 1979-09-03 | 1984-08-02 | 東レ株式会社 | 5,6,7−トリノル−4,8−インタ−m−フエニレンPGI↓2誘導体 |
DE3041601A1 (de) * | 1980-10-31 | 1982-06-16 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
JPS57144276A (en) * | 1981-03-03 | 1982-09-06 | Toray Ind Inc | 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative |
JPS58124778A (ja) * | 1982-01-20 | 1983-07-25 | Toray Ind Inc | 5,6,7−トリノル−4,8−インタ−m−フエニレンPGI↓2誘導体 |
DE3322893A1 (de) * | 1983-06-23 | 1985-01-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
PT90888B (pt) * | 1988-06-17 | 1994-12-30 | Wellcome Found | Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas |
DE4104607A1 (de) * | 1991-02-12 | 1992-08-13 | Schering Ag | Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen |
CA2188931C (en) * | 1995-02-27 | 2007-09-11 | Reiji Kasukawa | Agent for treating cor pulmonale |
-
1998
- 1998-02-26 EP EP98905676A patent/EP0925787A4/en not_active Withdrawn
- 1998-02-26 CN CN199898800548A patent/CN1224354A/zh active Pending
- 1998-02-26 CA CA002253717A patent/CA2253717A1/en not_active Abandoned
- 1998-02-26 KR KR1019980708584A patent/KR20000065039A/ko not_active Application Discontinuation
- 1998-02-26 AU AU61173/98A patent/AU6117398A/en not_active Abandoned
- 1998-02-26 WO PCT/JP1998/000801 patent/WO1998037895A1/ja not_active Application Discontinuation
- 1998-10-26 NO NO984974A patent/NO984974L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CN1224354A (zh) | 1999-07-28 |
AU6117398A (en) | 1998-09-18 |
EP0925787A4 (en) | 1999-12-01 |
EP0925787A1 (en) | 1999-06-30 |
KR20000065039A (ko) | 2000-11-06 |
NO984974D0 (no) | 1998-10-26 |
CA2253717A1 (en) | 1998-09-03 |
WO1998037895A1 (fr) | 1998-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0913156T3 (da) | Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis | |
NO20051987L (no) | Behandling av soppinfeksjoner. | |
BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
DE69722401D1 (de) | Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods | |
NO20055152L (no) | Karbonstyrilderivater og humor stabiliserende midler for behandling av humor forstyrrelser | |
BRPI0515600A (pt) | formas farmacêuticas opióides tendo cmédia e auc em estado estável proporcionais à dose e cmax de dose única inferior ao proporcional à dose | |
WO1999046279A3 (en) | INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE | |
DK0853660T3 (da) | Fremgangsmåde til opbevaring af infektiøse rekombinante virusser, vandig virussuspension og anvendelse som lægemiddel | |
NO20052348L (no) | Behandling av hemoragisk sjokk | |
WO2003062273A3 (en) | Modulator of the notch signalling pathway and use thereof in medical treatment | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
NO984974L (no) | Middel som forbedrer pulmonar sirkulasjon | |
HUP9801924A2 (hu) | Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény | |
EP1425047A4 (en) | METHOD FOR IMPROVING OXYGEN TRANSPORT WITH STORED RED GLOBLES | |
Lishner et al. | Treatment of diabetic perforating ulcers (mal perforant) with local dimethylsulfoxide | |
NO985571L (no) | Legemiddel for autoimmunsykdommer | |
NO985908L (no) | FremgangsmÕte til Õ behandle leversykdom og liknende indikasjoner med vasodilaterende midler | |
DK1331940T3 (da) | Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2 | |
NO20005223L (no) | Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen | |
Pandey et al. | Protective effects of aprotinin on respiratory and cardiac abnormalities induced by Mesobuthus tamulus venom in adult rats | |
HK1045456A1 (en) | Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection | |
WO2006020912A3 (en) | Treatments for congestive heart failure | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
NO951762D0 (no) | Stabilt preparat for behandling av blodkoagulasjonssykdommer, omfattende et aktivt koagulasjonsfremmende stoff | |
Lacroix et al. | Population pharmacokinetics of brivaracetam in patients with partial epilepsy |